
21.71 Delayed Data As of 3:59pm ET | ![]() Today’s Change | 17.97 Today|||52-Week Range 30.35 | +3.23% Year-to-Date |
The Nasdaq Is Rebounding: 2 Supercharged Growth Stocks to Buy in February Feb 01 / MotleyFool.com - Paid Partner Content |
Previous close | 22.53 |
Today’s open | 22.33 |
Day’s range | 21.68 - 22.54 |
Volume | 24,131 |
Average volume (3 months) | 886,406 |
Market cap | $1.4B |
Earnings growth (last year) | +15.55% |
Earnings growth (this year) | -46.74% |
Earnings growth (next 5 years) | 0.00% |
Revenue growth (last year) | +14.71% |
P/E ratio | NM |
Price/Sales | 8.16 |
Price/Book | 4.48 |
Today’s change | Today’s % change | |
---|---|---|
DVAXDynavax Technologies... | -0.21 | -1.72% |
RCUSArcus Biosciences In... | -0.66 | -3.12% |
---- | ||
AUPHAurinia Pharmaceutic... | -0.25 | -2.74% |
Next reporting date | February 28, 2023 |
EPS forecast (this quarter) | -$1.07 |
Annual revenue (last year) | $227.5M |
Annual profit (last year) | -$180.1M |
Net profit margin | -79.16% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters San Diego, California |